The BAG5 Knockout PaTu 8988t Polyclonal Cells product provides a polyclonal cell population derived from the PaTu 8988t human pancreatic ductal adenocarcinoma cell line, engineered via CRISPR/Cas9-mediated disruption of the BAG5 gene. This gene-edited model enables loss-of-function studies to dissect the biological roles of BAG5 in a cancer-relevant epithelial environment. The polyclonal format captures the heterogeneous editing outcomes typical of CRISPR/Cas9 experiments, facilitating robust analysis of BAG5-dependent phenotypes across a diverse cellular background.
The host cell line, PaTu 8988t, is an epithelial cell line established from a human pancreatic tumor, and it is widely used as a model system for pancreatic ductal adenocarcinoma (PDAC) research. Characterized by its adherent growth and epithelial morphology, PaTu 8988t retains key genomic and signaling features of primary pancreatic tumors. This makes it an appropriate platform for investigating oncogenic mechanisms, tumor cell signaling, and drug response in a clinically relevant cellular context.
BAG5 encodes a co-chaperone that modulates the activity of the Hsp70 family of chaperones, thereby influencing critical cellular processes such as apoptosis and autophagy. BAG5 directly interacts with Hsp70 and Hsc70, as well as with BCL2, BAX, and the E3 ubiquitin ligase CHIP. Through these interactions, BAG5 regulates the Hsp70 chaperone cycle and participates in the control of the intrinsic apoptosis pathway and autophagic flux. Upstream, BAG5 expression is responsive to stress stimuli including heat shock, endoplasmic reticulum stress, and signals from the BCL2 family. Downstream, BAG5 influences caspase activation, BCL2 anti-apoptotic function, and the autophagy machinery, including ATG5. Thus, BAG5 serves as a molecular nexus linking protein quality control, apoptosis signaling, and autophagy.
Disruption of BAG5 in PaTu 8988t cells provides a powerful tool for examining the interplay between protein homeostasis, cell death, and survival in pancreatic cancer. Given that BAG5 modulates interactions with Hsp70 and BCL2, its knockout is expected to impair protein quality control and stress adaptation, potentially reducing the tumorigenic capacity of these cells. This model is particularly relevant for studying how pancreatic cancer cells evade apoptosis and sustain growth under adverse conditions, including therapeutic stress. Researchers can employ this system to explore mechanisms of drug resistance and to identify vulnerabilities arising from compromised chaperone networks.
The BAG5 Knockout PaTu 8988t Polyclonal Cells are suitable for a range of experimental applications, including cancer cell biology, apoptosis research, autophagy analysis, and pancreatic cancer modeling. Typical assays such as Western blotting, RT-qPCR, apoptosis assays, co-immunoprecipitation, flow cytometry, cell viability, migration, and drug sensitivity studies can be performed to assess functional consequences of BAG5 loss. The polyclonal nature supports screening for phenotypic heterogeneity and identification of BAG5-dependent signaling nodes. For further information, please contact Ascent Research.
